From the journal article, we don't know if they're picking ALL lesions that are 2mm. You're extrapolating your assumptions, where the research has not indicated this at all. There is a long way to go to determine a level playing field yet flotsam.
i agree there are plenty of cheerleaders for cu6, but I think you're pushing the whole new pet ct leveling the whole playing field a bit too much. Once there is more data regarding these new ct scanners, and it shows this unequivocally to be the case, I'll agree with you.
- Forums
- ASX - By Stock
- CU6
- Ann: Last patient assessment completed for SARTATE trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
6.01%
!
$4.38

Ann: Last patient assessment completed for SARTATE trial, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.38 |
Change
-0.280(6.01%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$4.62 | $4.65 | $4.30 | $18.54M | 4.185M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 14980 | $4.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 2500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 14980 | 4.350 |
1 | 460 | 4.340 |
1 | 575 | 4.320 |
4 | 22231 | 4.300 |
2 | 7000 | 4.290 |
Price($) | Vol. | No. |
---|---|---|
4.390 | 2500 | 1 |
4.400 | 17000 | 1 |
4.420 | 20000 | 1 |
4.440 | 7029 | 1 |
4.450 | 9100 | 3 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |